Renli Teng received his B.S. degree and Pharmacy Graduate degrees from Shenyang College of Pharmacy and his Ph.D. degree in pharmacokinetics and Pharmacodynamics from the College of Pharmacy, University of Kentucky,Lexington,KY, USA. Dr.Teng also spent 2 years in a Postgraduate training in the College of Pharmacy, University of California,San Francisco,Calif,USA. Dr.Teng is serving as a Senior Director of clinical pharmacology and Senior clinical Pharmacologist at AstraZeneca, Wilmington,Del,USA and a Visiting Professor at Shenyang Pharmaceutical University, China. Dr. Teng’s principal expertise includes clinical pharmacology, drug metabolism, pharmacokinetics, pharmacodynamics and biopharmaceutics with emphasis on pediatric clinical pharmacology,and the evaluation of pediatric formulations clinically, ethnicity differences in PK and PD and dose adjustments by ethnicity and antiplatelet clinical pharmacology and its management for atherothrombotic disease.
Biography Updated on 27 June 2012